Independent Pharmacy Review vs Dispensing Pharmacy Review
Not all pharmacy reviews are created equal. Independence from dispensing eliminates structural conflicts that systematically bias medication recommendations.
Published 3 April 2026
The Independence Question
Your medication reviews may come from independent pharmacists or from the dispensing pharmacies managing your claimant's prescriptions. These represent fundamentally different services with different reliability profiles.
Independence in review isn't about competence. Dispensing pharmacists are highly qualified. Independence matters because it removes structural financial incentives that systematically bias recommendations toward medication continuation.
What Is Independent Pharmacy Review?
Independent pharmacy review is conducted by pharmacists with no financial relationship to dispensing. Your independent reviewer earns no revenue from dispensing medications, creating freedom to recommend any action including medication cessation.
Independence Structure
Independent pharmacists are engaged specifically for review services, not medication dispensing. They may work for review services, insurance consultancies, or specialist medication management organisations. Critically, their revenue comes from review services, not from dispensing.
Independence Characteristics
Independent reviewers have: no financial stake in continued dispensing, no relationship with treating pharmacies, no incentive to recommend medication continuation, and no implicit pressure to maintain professional relationships with dispensing pharmacists.
Independence Implications
Without financial incentive for medication continuation, independent reviewers can recommend deprescribing freely. They can identify medication problems without concern that the identification threatens their business model.
What Is Dispensing Pharmacy Review?
Dispensing pharmacy review is conducted by the community pharmacy managing your claimant's medications. The same pharmacy dispensing prescriptions also reviews appropriateness.
Dispensing Structure
Community pharmacies often offer medication review as a service. The reviewing pharmacist works for the same organisation dispensing medications. Revenue from dispensing funds the pharmacy's operations.
Conflict of Interest
The core issue: the pharmacy profits from dispensing. Recommending medication cessation reduces that profit. This creates a structural conflict where the financial incentive is to recommend medication continuation.
Conflict Expression
This conflict isn't necessarily expressed as conscious bias. Most dispensing pharmacists are honest professionals. The conflict emerges structurally through subtle patterns: problems minimised, recommendations hedged, deprescribing opportunities missed.
Real-World Differences in Recommendations
Research demonstrates systematic differences in recommendations between independent and dispensing reviewers examining the same medication list:
Medication Problem Identification
Independent reviewers identify more medication problems than dispensing pharmacies reviewing identical cases. The difference isn't competence; it reflects financial incentive differences.
Deprescribing Recommendations
Independent reviewers recommend medication cessation more frequently. Dispensing pharmacies, facing implicit pressure to maintain revenue, recommend cessation less frequently.
Characterisation of Appropriateness
Identical medication problems receive different characterisation. Independent review: "This medication is inappropriate and should be ceased." Dispensing pharmacy review: "This medication could be monitored further."
Medication Interaction Assessment
Serious medication interactions may be characterised as "manageable" by dispensing pharmacies but "requiring urgent action" by independent reviewers. Same clinical situation; different framing based on financial incentives.
The Financial Incentive Structure
Understanding how incentives work helps explain review differences:
Margin Considerations
Dispensing pharmacies earn different margins on different medications. Some medications have higher margins. Subtle bias may favour higher-margin products over lower-margin equivalents.
Volume Considerations
Your claimant on more medications generates more pharmacy visits, more dispensing events, more opportunities for ancillary services. The pharmacy's financial interest lies in medication accumulation.
Implicit Pressure
The conflict isn't necessarily conscious. Pharmacists develop relationships with prescribers. Recommending deprescribing that contradicts prescriber's decisions creates professional tension. Dispensing pharmacies have subtle incentive to avoid conflict.
Documented Bias Patterns in Dispensing Pharmacy Reviews
Systematic patterns emerge in dispensing pharmacy reviews:
| Bias Pattern | How It Manifests | Impact on Your Claimant |
|---|---|---|
| Minimisation of drug interactions | Serious interactions characterised as manageable | Risky combinations continue; claimant harm not prevented |
| Acceptance of polypharmacy | Multiple medications for same condition accepted as normal | Unnecessary medications continue; deprescribing opportunities missed |
| Deference to prescriber authority | Prescription accepted as correct because doctor prescribed it | Inappropriate prescriptions continue; pharmacy's role reduced to mechanical dispensing |
| Passive response to medication accumulation | Medications added but never reviewed for continued necessity | Claimant accumulates unnecessary medications; recovery slowed |
| Preference for continuation | Recommendations favour starting new medications over ceasing existing ones | Regimen grows; complexity increases; side effects accumulate |
| Expensive product preference | Higher-margin brand names suggested over generic equivalents | Costs increase unnecessarily; clinical outcomes identical but expense higher |
Comparison: Same Claimant, Different Recommendations
Consider how different reviewer types might assess identical medication list:
Scenario: Your claimant, 72 years old, recovering from hip fracture. Current medications: paracetamol, ibuprofen, tramadol (opioid), omeprazole (acid suppression), sertraline (antidepressant), atorvastatin (cholesterol), ramipril (blood pressure), atenolol (blood pressure), furosemide (diuretic), zopiclone (sleep).
Dispensing Pharmacy Assessment: "Medications are generally appropriate. Claimant taking them well. Consider monitoring tramadol dose. Sleep medication helps claimant rest for rehabilitation. Blood pressure medications optimised. Continue current regimen with monitoring."
Independent Review Assessment: "Significant medication problems identified. Triple pain medication (paracetamol, ibuprofen, tramadol) is excessive and creates GI bleeding risk, particularly with acid suppression masking symptoms. Benzodiazepine-class sleep medication in elderly orthopedic patient creates significant fall risk. Dual blood pressure medication agents (ramipril plus beta-blocker) with concurrent diuretic creates fall risk and electrolyte concerns. Recommendations: cease ibuprofen, consolidate pain management to tramadol or paracetamol alone, cease zopiclone with psychology support for alternative sleep management, review blood pressure medications for deprescribing potential, reconsider need for ongoing acid suppression once NSAIDs ceased."
Same claimant. Identical medication list. Vastly different assessments. The difference reflects structural incentive differences, not competence differences.
Why Your Claims Benefit From Independence
Independent review produces better claim outcomes:
Medication Optimisation
Independent review identifies medication problems that dispensing pharmacy reviews systematically miss. Your claimant benefits from medication regimen actually optimised for their recovery.
Deprescribing Opportunities
Independent reviewers actively seek deprescribing opportunities. Your claimant's unnecessary medications are identified and planned for cessation, reducing side effects and improving function.
Clear Clinical Communication
Independent recommendations are unequivocal. "This medication should be ceased" is clear directive rather than hedged suggestion. Prescribers understand the clinical concern precisely.
Faster Recovery
Claimants receiving truly optimised medication regimens recover faster. Reduced side effects, deprescribed unnecessary medications, and appropriate dose adjustments all support better recovery.
Reduced Claim Duration
Faster recovery and reduced medication-related complications shorten claims. Your claimant returns to function and work sooner.
Better Long-Term Outcomes
Claimants receiving appropriate medication regimens avoid chronic medication dependence, medication-related disability, and extended claim duration that accumulating, inappropriate polypharmacy creates.
Recognising Independence in Reviews
When assessing whether your review is independent, look for:
Review Source
Is the reviewer employed by an independent organisation or by the dispensing pharmacy? Independent status requires genuine organisational separation.
Financial Relationship
Does the reviewer earn revenue from dispensing? True independence means zero revenue from dispensing activities.
Pharmacy Relationships
Does the reviewer have professional relationships with dispensing pharmacies that might create subtle pressure to align recommendations? Independence means no ongoing relationships with treating pharmacies.
Explicit Statement of Independence
The review report should explicitly state independence from dispensing and absence of conflicts of interest. This transparency matters.
Deprescribing Recommendations
Reviews that never recommend deprescribing are suspect. True assessment of medication regimens regularly identifies unnecessary medications. Absence of deprescribing recommendations suggests systematic bias.
Integrating Independent Review With Community Pharmacy
Independence and community pharmacy involvement aren't mutually exclusive:
Optimal Approach: Independent review identifies medication optimisation strategy. Community pharmacy implements strategy and manages ongoing medication administration and adherence support.
Benefit: Your claimant receives both unbiased clinical assessment (independent review) and continuity of care (community pharmacy relationship).
Implementation: Independent pharmacist and community pharmacist communicate regarding recommendations. Community pharmacy understands clinical rationale and supports implementation.
The Business Case for Independent Review
Independent review benefits your organisation financially:
- Deprescribing identifies cost savings: Unnecessary medications are ceased, reducing medication costs directly
- Shorter claim duration: Better medication management produces faster recovery and shorter claims
- Reduced adverse events: Medication-related complications are prevented, reducing secondary treatment costs
- Better rehabilitation outcomes: Claimants on optimised regimens participate better in rehabilitation
- Return-to-work acceleration: Improved function from appropriate medication management speeds return to work
- Reduced litigation risk: Appropriate medication recommendations reduce liability from medication-related harm
The investment in independent review typically produces multifold return through improved claim outcomes.
Your Review Selection Strategy
When choosing between review types, ask these questions:
Question 1: Is the Reviewer Independent From Dispensing?
No financial interest in dispensing? Genuine independence exists. Otherwise, suspect systematic bias.
Question 2: Does Review Include Deprescribing Recommendations?
Appropriately identified unnecessary medications with cessation recommendations? Independence likely. No deprescribing recommendations despite polypharmacy? Bias suspected.
Question 3: Are Recommendations Clear and Unequivocal?
Clear directive for action? Independent. Hedged, ambiguous recommendations? Potential bias from conflicted interests.
Question 4: Does Review Report State Independence Explicitly?
Explicit statement of independence and absence of conflicts? Transparency about reviewer status matters.
Ensure your medication reviews are truly independent.
IMM provides completely independent pharmacy review. We earn no revenue from dispensing, ensuring our recommendations reflect clinical evidence, not financial incentives. Your claims receive unbiased assessment focused entirely on your claimant's recovery.
Request a Medication Review
